# A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06341114/  
OnCo record `nct06341114` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of BAT8008 injection in advanced solid tumours, run by Bio-Thera Solutions, active and no longer recruiting.

## Summary

A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06341114 by Bio-Thera Solutions, with 112 participants enrolled, started 2024-04-12 and due to reach its primary completion in 2026-04-03. Interventions recorded: BAT8008 injection and BAT1308 injection.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06341114
- Phase: 1/2
- Setting: A Multicenter, Open-label Phase Ib-II Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
- Sponsor: Bio-Thera Solutions
- Enrolled: 112

## Sources

- ClinicalTrials.gov NCT06341114: https://clinicaltrials.gov/study/NCT06341114

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- companies: [Bio-Thera Solutions](https://onco.cc/companies/bio-thera-solutions/)

---
JSON: https://onco.cc/api/v1/entities/nct06341114.json